BioNTech SE

Passed

Class Action Period:
March 30, 2022 - October 13, 2023

Lead Plaintiff Deadline:
March 12, 2024

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.












The submission of this form does not create an attorney-client relationship.

Allegations

The filed complaint alleges that BioNTech SE made materially false and/or misleading statements and/or failed to disclose that: (i) BioNTech overstated demand for and/or the commercial prospects of Comirnaty, the COVID-19 vaccine developed by the Company in collaboration with Pfizer ; (ii) the Company and/or Pfizer had accumulated excess inventory of raw materials for Comirnaty, as well as COVID-19 vaccine doses adapted to other, non-XBB.1.5 variants that were produced at risk; (iii) accordingly, BioNTech was at an increased risk of recording significant inventory write-offs and other charges related to Comirnaty; and (iv) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of BioNTech purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in BioNTech during the relevant time frame, you have until March 12, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.